KeyMed Biosciences Inc
HKEX:2162
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
K
|
KeyMed Biosciences Inc
HKEX:2162
|
CN |
|
TPI Triunfo Participacoes e Investimentos SA
BOVESPA:TPIS3
|
BR |
|
M
|
Mural Oncology PLC
NASDAQ:MURA
|
IE |
|
Grupo Ortiz Properties SOCIMI SA
MAD:YGOP
|
ES |
|
A
|
Alset Ehome International Inc
NASDAQ:AEI
|
US |
Wall Street
Price Targets
Price Targets Summary
KeyMed Biosciences Inc
According to Wall Street analysts, the average 1-year price target for KeyMed Biosciences Inc is 85.05 HKD with a low forecast of 71.46 HKD and a high forecast of 98.25 HKD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is KeyMed Biosciences Inc's stock price target?
Price Target
85.05
HKD
According to Wall Street analysts, the average 1-year price target for KeyMed Biosciences Inc is 85.05 HKD with a low forecast of 71.46 HKD and a high forecast of 98.25 HKD.
What is KeyMed Biosciences Inc's Revenue forecast?
Projected CAGR
64%
The compound annual growth rate of KeyMed Biosciences Inc's revenue for the next 4 years is 64%.
